These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25902477)

  • 1. Brains, Blood, and Guts: MeCP2 Regulates Microglia, Monocytes, and Peripheral Macrophages.
    Schafer DP; Stevens B
    Immunity; 2015 Apr; 42(4):600-2. PubMed ID: 25902477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli.
    Cronk JC; Derecki NC; Ji E; Xu Y; Lampano AE; Smirnov I; Baker W; Norris GT; Marin I; Coddington N; Wolf Y; Turner SD; Aderem A; Klibanov AL; Harris TH; Jung S; Litvak V; Kipnis J
    Immunity; 2015 Apr; 42(4):679-91. PubMed ID: 25902482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microglia in brain maintenance: implications for Rett syndrome.
    Derecki NC; Cronk JC; Kipnis J
    Trends Immunol; 2013 Mar; 34(3):144-50. PubMed ID: 23122051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress.
    Zhao D; Mokhtari R; Pedrosa E; Birnbaum R; Zheng D; Lachman HM
    Mol Autism; 2017; 8():17. PubMed ID: 28367307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
    Buschdorf JP; Strätling WH
    J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity.
    Jin LW; Horiuchi M; Wulff H; Liu XB; Cortopassi GA; Erickson JD; Maezawa I
    J Neurosci; 2015 Feb; 35(6):2516-29. PubMed ID: 25673846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia contribute to circuit defects in Mecp2 null mice independent of microglia-specific loss of Mecp2 expression.
    Schafer DP; Heller CT; Gunner G; Heller M; Gordon C; Hammond T; Wolf Y; Jung S; Stevens B
    Elife; 2016 Jul; 5():. PubMed ID: 27458802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Unresolved Inflammation in the
    Cortelazzo A; De Felice C; De Filippis B; Ricceri L; Laviola G; Leoncini S; Signorini C; Pescaglini M; Guerranti R; Timperio AM; Zolla L; Ciccoli L; Hayek J
    Mediators Inflamm; 2017; 2017():9467819. PubMed ID: 28592917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome.
    Amano K; Nomura Y; Segawa M; Yamakawa K
    J Hum Genet; 2000; 45(4):231-6. PubMed ID: 10944854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in dopaminergic neurons differentiated from exfoliated deciduous tooth-derived pulp stem cells of a child with Rett syndrome.
    Hirofuji S; Hirofuji Y; Kato H; Masuda K; Yamaza H; Sato H; Takayama F; Torio M; Sakai Y; Ohga S; Taguchi T; Nonaka K
    Biochem Biophys Res Commun; 2018 Apr; 498(4):898-904. PubMed ID: 29534967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
    Martínez de Paz A; Ausió J
    Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation in the gene body influences MeCP2-mediated gene repression.
    Kinde B; Wu DY; Greenberg ME; Gabel HW
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of epigenetics in Rett syndrome.
    Kubota T; Miyake K; Hirasawa T
    Epigenomics; 2013; 5(5):583-92. PubMed ID: 24059803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MeCP2 and other methyl-CpG binding proteins.
    Jørgensen HF; Bird A
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):87-93. PubMed ID: 12112733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice.
    Bissonnette JM; Knopp SJ
    Pediatr Res; 2006 Apr; 59(4 Pt 1):513-8. PubMed ID: 16549521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MeCP2 in central nervous system glial cells: current updates.
    Sharma K; Singh J; Frost EE; Pillai PP
    Acta Neurobiol Exp (Wars); 2018; 78(1):30-40. PubMed ID: 29694339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular pathology of Rett syndrome: synopsis and update.
    Akbarian S; Jiang Y; Laforet G
    Neuromolecular Med; 2006; 8(4):485-94. PubMed ID: 17028371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations and polymorphisms in the human methyl CpG-binding protein MECP2.
    Miltenberger-Miltenyi G; Laccone F
    Hum Mutat; 2003 Aug; 22(2):107-15. PubMed ID: 12872250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.